NANNETTI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 1513
EU - Europa 127
AS - Asia 52
Totale 1692
Nazione #
US - Stati Uniti d'America 1512
IT - Italia 52
CN - Cina 43
FI - Finlandia 23
SE - Svezia 22
DE - Germania 19
VN - Vietnam 5
FR - Francia 4
KR - Corea 3
UA - Ucraina 3
CA - Canada 1
GB - Regno Unito 1
IN - India 1
NL - Olanda 1
PT - Portogallo 1
RO - Romania 1
Totale 1692
Città #
Fairfield 320
Woodbridge 155
Ann Arbor 151
Houston 150
Ashburn 122
Seattle 118
Chandler 117
Cambridge 113
Wilmington 101
San Diego 29
Medford 18
Princeton 18
Boardman 17
Padova 15
Helsinki 14
Roxbury 13
Des Moines 11
Nanjing 9
Dearborn 8
Dong Ket 5
Beijing 4
Florence 3
Hebei 3
Hefei 3
Kharkiv 3
Kunming 3
Nanchang 3
Nürnberg 3
Shenyang 3
Taiyuan 2
Turin 2
Zhengzhou 2
Abano Terme 1
Aprilia 1
Berlin 1
Borås 1
Bucharest 1
Changsha 1
Chengdu 1
Desio 1
Figline Valdarno 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Jiaxing 1
Jinan 1
Langfang 1
Las Vegas 1
Munich 1
Perugia 1
Quzhou 1
Reggio Calabria 1
Rockville 1
Salerno 1
San Francisco 1
Santa Clara 1
Siena 1
Taizhou 1
Trapani 1
Varese 1
Verona 1
Wuhan 1
Totale 1568
Nome #
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 157
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 131
Antiviral strategies against influenza virus: towards new therapeutic approaches. 129
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 127
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 123
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 115
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 111
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 109
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 107
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 98
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 97
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 94
A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma 90
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 77
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 65
Corrigendum to “Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity” [Eur. J. Med. Chem. 138 (2017) 128–139] (S0223523417304610) (10.1016/j.ejmech.2017.06.015)) 56
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 40
Sviluppo e caratterizzazione di nuovi inibitori diretti contro la polimerasi dei virus dell'influenza di tipo A e B 21
Totale 1747
Categoria #
all - tutte 2720
article - articoli 2633
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201820 0000 05 22 0371
2018/2019170 3061 13 40 1306556
2019/2020557 41151370 7146 7265 81353711
2020/2021292 25181217 715 1125 50105646
2021/2022332 8582829 4121 1834 9111659
2022/2023191 4741538 600 00 0000
Totale 1747